Alzheimer's Disease
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Global Alzheimer's disease market intelligence for pharma BD, investors & analysts. Track drug development, clinical trials & regulatory updates.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Alzheimer's Disease hub for NMPA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Clinical Trials Outsourcing Market Size: 2026-2034 Growth Outlook
Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.